Noctiva

Active Ingredient(s): Desmopressin Acetate
FDA Approved: * March 3, 2017
Pharm Company: * SERENITY PHARMS LLC
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Noctiva Overview

Desmopressin, sold under the trade names DDAVP among others, is a medication used to treat diabetes insipidus, bedwetting, hemophilia A, von Willebrand disease, and high blood urea levels. In hemophilia A and von Willebrand disease, it should only be used for mild to moderate cases. It may be give in the nose, by injection into a vein, by mouth, or under the tongue.[1] Common side effects include headaches, diarrhea, and low blood sodium. The low blood sodium that results may cause seizures. ...

Read more Noctiva Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Desmopressin

Recent Noctiva Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Desmopressin Acetate
  • Injection: 0.004mg/ml, 0.015mg/ml, 4mcg/ml
  • Solution: 0.01%
  • Spray: 0.83mcg/0.1ml, 1.66mcg/0.1ml
  • Spray, Metered: 0.01mg/actuation, 0.01mg/spray, 0.15mg/spray, 1.5mg/spray, 150mcg/actuation
  • Tablet: 0.1mg, 0.2mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Desmopressin Acetate or a similar ingredient: (6 results)